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Abstract
Mutations in the FUS gene cause amyotrophic lateral sclerosis (ALS-FUS). Mutant FUS is known to confer
cytoplasmic gain of function but its effects in the nucleus are less understood. FUS is an essential component of
paraspeckles, subnuclear bodies assembled on a lncRNA NEAT1. Paraspeckles may play a protective role specifically
in degenerating spinal motor neurons. However it is still unknown how endogenous levels of mutant FUS would
affect NEAT1/paraspeckles. Using novel cell lines with the FUS gene modified by CRISPR/Cas9 and human patient
fibroblasts, we found that endogenous levels of mutant FUS cause accumulation of NEAT1 isoforms and
paraspeckles. However, despite only mild cytoplasmic mislocalisation of FUS, paraspeckle integrity is compromised
in these cells, as confirmed by reduced interaction of mutant FUS with core paraspeckle proteins NONO and SFPQ
and increased NEAT1 extractability. This results in NEAT1 localisation outside paraspeckles, especially prominent
under conditions of paraspeckle-inducing stress. Consistently, paraspeckle-dependent microRNA production, a
readout for functionality of paraspeckles, is impaired in cells expressing mutant FUS. In line with the cellular data,
we observed paraspeckle hyper-assembly in spinal neurons of ALS-FUS patients. Therefore, despite largely
preserving its nuclear localisation, mutant FUS leads to loss (dysfunctional paraspeckles) and gain (excess of free
NEAT1) of function in the nucleus. Perturbed fine structure and functionality of paraspeckles accompanied by
accumulation of non-paraspeckle NEAT1 may contribute to the disease severity in ALS-FUS.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a severe adult-onset
neurodegenerative disease affecting motor neurons. More
than 20 genes have been linked to familial (f)ALS, and
many of them encode RNA-binding proteins, including
FUS [61]. Over 50 mutations in the FUS gene have been
found in fALS and sporadic (s)ALS patients, the vast
majority being heterozygous mutations with autosomal
dominant inheritance; most of them affect the nuclear
localization signal (NLS) of the protein [31, 33, 34, 65].
Mutations in the FUS gene cause an aggressive, some-
times juvenile-onset disease [34].
The histopathological hallmark of ALS-FUS is partial
mislocalisation of this predominantly nuclear protein to
the cytoplasm in neurons and glial cells of the spinal
cord and formation of FUS-positive inclusions [23, 31,
65]. It should be noted, however, that significant FUS
mislocalisation is seen only in a subset of ALS-FUS cases
and only in a subset of neurons in the latter cohort [23,
29, 39], suggesting that altered nuclear function(s) of
mutant FUS can drive pathological changes sufficient to
cause the disease. Indeed, FUS mutations having only a
minor effect on its nuclear import, such as R521G(H),
are detrimental in in vitro and in vivo models [47, 49,
51, 66]. In addition, ALS-linked FUS mutations outside
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its NLS have been identified [64], and they also cause
pathological cellular phenotypes [45, 46]. Finally, most
recent studies from mouse models of FUS pathology re-
vealed that mutant FUS is able to cause neurodegenera-
tion in the absence of cytoplasmic pathology and even
significant mislocalisation, strongly suggesting that nu-
clear gain of toxic function by mutant FUS represents
an important disease mechanism [15, 37]. Despite signifi-
cant progress in our understanding of cytoplasmic gain of
function by mutant FUS [19], nuclear mechanisms of mu-
tant FUS toxicity are still poorly understood.
Paraspeckles are RNA granules formed in the nuclear
interchromatin space, in close proximity to splicing
speckles [20]. Paraspeckles contain several core and
multiple secondary proteins that are assembled on a
scaffold long non-coding RNA (lncRNA) NEAT1 [12,
42, 50, 58]. The NEAT1 gene produces two transcripts,
NEAT1_1 and NEAT1_2; only the longer isoform,
NEAT1_2, is capable of forming paraspeckles [42].
Established functions of paraspeckles include sequestra-
tion of some RNAs and transcription factors, and thus
regulation of gene expression, in response to certain
stimuli such as proteasomal inhibition and viral infec-
tion [1, 10, 24, 26, 73]. Most recently, roles for para-
speckles in enhancing microRNA biogenesis and
regulation of mitochondrial function have been identi-
fied [27, 67]. Dysfunction of paraspeckles or their com-
ponents is implicated in the increasing number of
human diseases, including cancer, autoimmune and
neurodegenerative disorders [21].
FUS is involved in multiple processes related to cellular
RNA metabolism [48]. The protein possesses a
low-complexity prion-like domain responsible for its ability
to phase-separate and to be recruited into RNA granules in
the nucleus or cytoplasm [6, 56]. Although normal and mu-
tant FUS are incorporated into a variety of RNA granules
and can even nucleate RNA granules when accumulated [3,
18, 54, 72], the paraspeckle is the only type of physiological
RNA granule which requires FUS as a structural compo-
nent. FUS is defined as an essential paraspeckle protein, in
that its knockdown eliminates paraspeckles [42, 55].
Paraspeckles likely play an important role in ALS patho-
genesis. Indeed, paraspeckle proteins are enriched in the
pool of proteins affected by ALS-causative mutations [2].
Although healthy mammalian neurons lack NEAT1_2 ex-
pression and hence paraspeckles in vitro and in vivo [43,
53], de novo paraspeckle formation is typical for spinal
motor neurons of sALS and fALS patients and as such
can be considered a hallmark of the disease [44, 53]. Previ-
ously, we reported pathological aggregation of a core para-
speckle protein, NONO, in cellular and mouse models of
FUS pathology as well as in the spinal cord of ALS-FUS
patients [55]. Since both FUS and NONO are required to
build paraspeckles, formation of these RNA granules was
expected to be disrupted in ALS-FUS. However, this as-
sumption has not been tested experimentally.
In the current study, using novel cell lines expressing
endogenous mutant FUS, patient fibroblasts and human
post-mortem tissue, we have identified excessive assem-
bly of dysfunctional paraspeckles as a novel nuclear
pathology caused by FUS mutations.
Materials and methods
Generation of cell lines with targeted modification of the
FUS gene
Guide RNA target sequences within the FUS gene were
identified using Feng Zhang lab’s Target Finder (https://
zlab.bio/guide-design-resources). Respective forward
and reverse oligonucleotides were annealed and cloned
into pX330-U6-Chimeric_BB-CBh-hSpCas9 (pX330)
vector (Addgene) according to the previously described
protocol [13]. SH-SY5Y human neuroblastoma cells
were split onto a 35 mm dish at 50–60% confluency
one day prior to transfection. Equal amounts of plas-
mids (3.6 μg each) carrying upstream and downstream
gRNA target sequence (or one plasmid for FUS knock-
out) were delivered into cells by calcium phosphate
transfection. After 24 h, cells were resuspended at ~
10–20 cells/ml and plated onto 10 cm dishes.
Single-cell derived clones were expanded and screened
by immunofluorescence and PCR. For sequencing of
the edited portion of FUS gene, the PCR product corre-
sponding to the edited allele was cloned into Zero
Blunt® TOPO® vector (Life Technologies), and at least
four colonies were sequenced. Primers used for PCR
screening and TOPO® cloning: ΔNLS lines: 5’-TGGG
GACAGAGGTGGCTTTG-3′ and 5’-CCTTCCTGA
TCGGGACATCG-3′; FUS KO: 5’-ACCATTTGAGAAA
GGCACGCT-3′ and 5’-CACGGATTAGGACACTTCC
AGT-3′.
Cell line maintenance, differentiation, transfection and
treatments
SH-SY5Y neuroblastoma cells were maintained in 1:1
mixture of Dulbecco’s Modified Eagle’s Medium and F12
medium supplemented with 10% fetal bovine serum
(FBS), penicillin-streptomycin and glutamine (all Invitro-
gen). Cells were transfected in 24-well plates with plasmid
DNA (200 ng/well), poly(I:C) (Sigma, 250 ng/well) or
siRNA (AllStars Negative Control from Qiagen or NEAT1
Silencer Select®, n272456 from Life Technologies) using
Lipofectamine2000. Final concentrations of MG132 and
sodium arsenite (both Sigma) were 1 μM and 0.05mM, re-
spectively. Cells were treated with actinomycin D for 3 h
to induce nucleolar caps. Plasmids for expression of
GFP-tagged FUS variants are described elsewhere [54].
Plasmids for NONO and SFPQ expression were prepared
by inserting respective ORFs into pEGFP-C1 vector. The
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protocol for obtaining human fibroblasts from a control
subject and a patient with FUS P525L mutation [9, 36]
was approved by the University of Palermo Review Board
(prot.07/2017). Human fibroblasts were cultured under
the same conditions as SH-SY5Y cells. Primary murine
hippocampal cultures were prepared and transfected as
described [30].
Immunocytochemistry, RNA-FISH and proximity ligation
assay (PLA) on cultured cells
Cells were fixed on coverslips with 4% paraformalde-
hyde for 15 min, washed with 1xPBS and permeabilized
in cold methanol (or 70% ethanol in case of RNA-FISH).
For immunostaining, coverslips were incubated with pri-
mary antibodies diluted in blocking solution (5% goat
serum/in 0.1% Tween 20/1xPBS) for 1 h at RT or at 4 °C
overnight. Secondary Alexa488- or Alexa546-conjugated
antibody was added for 1 h at RT. For RNA-FISH, com-
mercially available NEAT1 probes (Stellaris® Quasar®
570-labelled against 5′ or middle segment of human
NEAT1, Biosearch Technologies) and Cy5-labelled oli-
go(dT)30 probe (for polyA+ RNA detection, Sigma) were
used as per standard Biosearch Technologies protocol. For
colocalisation studies of NEAT1 and NONO, RNA-FISH
was followed by 30 min incubation in anti-NONO anti-
body and Alexa488-conjugated secondary antibody.
PLA was performed using Duolink® In Situ Orange
Starter Kit Mouse/Rabbit (DUO92102, Sigma) using
anti-FUS (mouse monoclonal, Santa Cruz, sc-47711)
antibody in combination with rabbit anti-NONO or
SFPQ (A301-322A, Bethyl) antibody. To detect FUS
and NONO interaction in paraspeckles, 1:10,000 anti-
body dilutions were used. Fluorescent images were cap-
tured using BX61 microscope equipped with F-View II
camera and processed using CellF software (all Olympus).
Quantification of paraspeckle numbers/NEAT1-positive
area and PLA results was performed using ‘Analyze parti-
cles’ tool of ImageJ software. Images were prepared using
Photoshop CS3 or PowerPoint 2010 software.
RNA analysis
Analysis NEAT1_2 and MALAT1 extractability was
performed as described [11]. Briefly, one set of samples
lysed in QIAzol (Qiagen) was heated at 55 °C for 10
min and the second set of samples prepared in parallel
was left at room temperature. RNA was extracted from
both sets as per standard QIAzol protocol. Fold extrac-
tion of NEAT1_2 or MALAT1 was calculated as a ratio
between levels of these RNAs, measured by qRT-PCR,
in heated versus non-heated samples. For obtaining nu-
clear soluble extract (SNE), a protocol by Werner and
Ruthenberg was followed [68]. For standard gene ex-
pression and miRNA analysis by qRT-PCR, total RNA
was extracted from cells using QIAzol with a heating
step (55 °C for 10 min). First-strand cDNA synthesis
was performed using random primers (or oligo(dT)
primers for NEAT1_1 analysis in SNE) and Superscript
IV (Invitrogen) or miScript II RT (Qiagen). Quantitative
RT-PCR was performed as described [30]; to measure
miRNA levels, forward miRNA-specific primer was
used in combination with the universal reverse primer
(unimiR). All primer sequences are given in Additional file 1:
Table S1. For RNA-Seq, total RNA was extracted using
PureLink total RNA extraction kit (Life Technologies) and
possible DNA contamination was removed using RNase
free DNase kit (Qiagen). RNA-Seq analysis was performed
at School of Biosciences Genomics Research Hub. Libraries
were prepared using the TruSeq stranded mRNA kit
(Illumina) and single-end sequencing was performed on
Illumina NextSeq500 (read length: 75 bp; coverage ~ 20
million reads/sample). Reads were aligned to the human
reference genome (GRCh38) using STAR [16], and FPKM
values were obtained using DESeq2 [38]. Reads were
viewed in the IGV browser [62].
Protein analysis
Nuclear-cytoplasmic fractionation was performed accord-
ing to a published protocol (REAP) [59]. Total cell lysates
and cytoplasmic fractions were prepared for Western blot
by adding 2xLaemmli buffer followed by denaturation at
100 °C for 5min. SDS-PAGE and detection of proteins
were carried out as described elsewhere [53]. Quantifica-
tion of Western blots was done using Image J and protein
levels were normalised to beta-actin.
Primary antibodies
The following commercial primary antibodies were used:
FUS full protein (rabbit polyclonal, 11,570–1-AP); FUS
N-terminus (rabbit polyclonal, Abcam, ab84078; aa. 1–
50); FUS C-terminus (Bethyl, A300-294A; aa. 500–526);
p54nrb/NONO (rabbit polyclonal C-terminal, Sigma);
SFPQ (rabbit monoclonal, ab177149, Abcam; rabbit poly-
clonal, A301-322A, Bethyl); beta-actin (mouse monoclo-
nal, A5441, Sigma). Antibodies were used at 1:500–1:1000
dilution for all applications unless stated otherwise.
Analysis of human tissue samples
Human spinal cord paraffin sections from clinically and
histopathologically characterised ALS cases and neuro-
logically healthy individuals were obtained from the
MRC London Neurodegenerative Diseases Brain Bank
(Institute of Psychiatry, Kings College, London) and
Sheffield Brain Tissue Bank. Consent was obtained
from all subjects for autopsy, histopathological assess-
ment and research in accordance with local and na-
tional Ethics Committee approved donation. Human
spinal cord sections for immunohistochemistry were
7 μm thick. Immediately after antigen retrieval in citrate
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buffer, slides were washed several times in 2xSSC prepared
with DEPC-treated water. Slides were incubated with
NEAT1 (5′ segment) Stellaris® probe diluted in hybridisa-
tion buffer (10% formamide/2xSSC; 5 μl probe in 200 μl
buffer per slide under a 24 × 60 mm coverslip) in a hu-
midified chamber at 37 °C overnight. Nuclei were stained
with DAPI. Paraspeckles were analysed using the same
microscope and camera as above (× 100 magnification).
For RNAscope® ISH analysis, Hs-NEAT1-long (411541)
probe (Advanced Cell Diagnostics) was used according to
manufacturer’s instructions. SFPQ immunohistochemistry
on spinal cord sections was performed using SFPQ
IHC-00304 antibody (Bethyl) as described earlier [55].
Quantifications and statistics
N in all cases indicates the number of biological repli-
cates. On all graphs, error bars represent SEM. Statis-
tical analysis was performed using GraphPad Prism 6
software. Mean values of biological replicates were
compared using appropriate tests (stated in figure leg-
ends). Significance levels are indicated with asterisks
(*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Results
Generation and characterisation of cell lines express-
ing endogenous mutant FUS.
The requirement of FUS for paraspeckle assembly
limits the use of cell models with FUS overexpression or
knockdown. Moreover, patient derived pluripotent cells
and neurons differentiated from these cells were also
unsuitable for this study since both of these cell types
lack paraspeckles [8, 43]. Therefore we chose to generate
human neuroblastoma SH-SY5Y cell lines expressing en-
dogenous mutant FUS.
The majority of known ALS-FUS linked mutations
disrupt the function of the NLS at the FUS C-terminus;
clinically more severe variants are associated with NLS
deletions [14, 34]. To mimic genetic alterations typical
for the majority of ALS-FUS cases, cell lines with the de-
letion of genomic sequences encoding the 12 C-terminal
amino acids of FUS were produced using CRISPR/Cas9
editing. For that, upstream and downstream guide RNA
target sequences in exons 14 and 15 of the FUS gene re-
spectively were chosen (Fig. 1a). Single-cell derived
clones were screened by FUS immunostaining, and cell
lines from 11 clones showing cytoplasmic redistribution
of FUS were established (Fig. 1b). PCR analysis and se-
quencing of the edited portion of the FUS gene showed
that 6 clones were homozygous and 5 clones were het-
erozygous for FUS NLS deletion (Fig. 1c, Additional file
1: Figure S1A). Interestingly, sequencing also revealed
that some clones which appeared heterozygous for the
FUS gene deletion by PCR (such as ΔNLS1) were in fact
homozygous for FUS protein truncation; in these clones,
inversion and re-insertion of the edited genomic DNA
fragment occurred (Additional file 1: Figure S1A).
RNA-Seq confirmed lower number of reads in the tar-
geted gene fragment between exons 14 and 15 in the het-
erozygous clones and their absence in the homozygous
clones (Fig. 1d). CRISPR/Cas9 was also used to obtain
FUS knockout (KO) cells which lacked FUS immunoreac-
tivity (Fig. 1b, Additional file 1: Figure S1B).
Analysis by qRT-PCR showed a small increase of FUS
mRNA in FUS ΔNLS lines, consistent with the ability
of FUS to autoregulate its own levels, and confirmed
the absence of WT FUS mRNA in the homozygous
lines (Fig. 1e). Western blot with an antibody against
FUS N-terminus showed normal levels of FUS protein
(Fig. 1f ). As expected, an antibody specific to the ex-
treme C-terminus of FUS (aa.500–526) detected no
FUS protein in the homozygous lines (such as ΔNLS1)
and its decreased levels in the heterozygous lines (such
as ΔNLS2) (Fig. 1f ). Western blot also confirmed the
absence of detectable FUS protein in the FUS KO line
(Fig. 1f ).
We noticed that FUS redistribution to the cytoplasm
was very modest in the heterozygous FUS ΔNLS lines.
In contrast, homozygous cells displayed dramatic FUS
mislocalisation, with the border between the nucleus
and cytoplasm in the FUS-immunostained cells often
indistinguishable (Fig. 1g). Subcellular fractionation con-
firmed almost normal retention of FUS in the nucleus in
the heterozygous lines (Fig. 1h). This pattern is different
from the predicted two-fold increase in the cytoplasmic
mislocalisation in the homozygous as compared to hetero-
zygous FUS ΔNLS lines and suggests that the presence of
non-mutated, nuclear localised FUS partially protects mu-
tant FUS from mislocalisation. Consistent with previous
literature, mutant FUS was readily recruited to cytoplas-
mic stress granules induced by oxidative stress (Additional
file 1: Figure S2).
Thus, we established cell lines with mild and severe mis-
localisation of endogenous FUS to the cytoplasm suitable
for the analysis of paraspeckles.
Mutant FUS induces the accumulation of NEAT1 isoforms
and excessive paraspeckle formation
We next used NEAT1 RNA-FISH to image paraspeckles
in the lines generated. In our analysis, we included three
homozygous and three heterozygous (hereafter ΔNLS_ho
and ΔNLS_het, respectively) FUS ΔNLS lines as well as
FUS KO cells.
As predicted, FUS KO cells were devoid of para-
speckles (Fig. 2a). A similar phenotype was detected in
ΔNLS_ho lines, consistent with significant FUS redistri-
bution to the cytoplasm, although residual paraspeckles
were present in some cells (Fig. 2a, arrowheads). FUS is
known to act as a molecular ‘glue’ to stick individual
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NEAT1 RNP complexes together, to form mature para-
speckles [70]. In accord with this, in FUS KO and ΔNLS_ho
cells, we observed multiple smaller NEAT1-positive dots
likely corresponding to NEAT1 RNP complexes - para-
speckle “primary units” (Fig. 2a, bottom panel insets). What
was surprising about our data however, was that ΔNLS_het
lines displayed apparently enhanced paraspeckle formation
further confirmed by automated quantification of para-
speckle numbers (Fig. 2a, b). In fact, these counts may be
an underestimation as paraspeckles often form clusters
counted as single foci, especially in ΔNLS_het cells (Fig. 2a,
arrows). We additionally measured the cumulative area of
all NEAT1-positive foci per nucleus, which also showed
~ 2-fold increase across ΔNLS_het lines (Fig. 2b). Since
paraspeckles are currently defined as structures containing
both NEAT1_2 and an essential paraspeckle protein [42],
we used double-labeling that confirmed the presence of
NONO in NEAT1_2 positive dots in ΔNLS_het lines (Fig.
2c). One of the distinctive characteristics of paraspeckle
proteins is their ability to redistribute to nucleolar caps
when transcription is inhibited [42, 52], and mutant FUS
preserved this property (Additional file 1: Figure S3A).
Fig. 1 Generation and characterisation of SH-SY5Y cell lines with targeted modifications of the endogenous FUS gene. a Structures of the FUS
gene and FUS protein together with the positions of CRISPR/Cas9 target sites chosen to delete the NLS-encoding fragment. PAM sequences are
in green, stop codon is highlighted in yellow and exons are in bold. b Subcellular distribution of FUS protein in FUS ΔNLS and FUS knockout
(KO) clones detected with N-terminal FUS antibody. c PCR genotyping of FUS ΔNLS clones. PCR with primers flanking the fragment to be deleted
(underlined in A) yields 595 and 265 bp fragments for WT and edited FUS alleles, respectively. d RNA-Seq reads for exons 14 and 15 of the FUS
gene in WT cells as well as heterozygous and homozygous FUS ΔNLS lines. Dashed lines indicate the deletion. e Analysis of FUS mRNA levels by
qRT-PCR in FUS ΔNLS lines. Diagram shows positions of primers for measuring total and WT mRNA (not drawn to scale, del denotes the deleted
region). Average values for three heterozygous (“het pooled”) and three homozygous (“ho pooled”) lines are also shown. N = 4–6, *p < 0.05,
****p < 0.0001 (one-way ANOVA). f Western blot analysis of FUS in FUS ΔNLS and FUS KO lines using antibodies recognising its N-terminal (aa.1–
50) or C-terminal (aa.500–526) segments. Note that mutant FUS possesses a FUS-unrelated C-terminal amino acid stretch both in ΔNLS1_ho and
ΔNLS2_het lines causing slower migration of the mutant protein (for protein sequences see Additional file 1: Figure S1A). g FUS distribution in
representative heterozygous and homozygous FUS ΔNLS lines. Nuclei border in homozygous cells is indicated with a dashed line. h FUS levels in
total lysates and cytoplasmic fraction from WT and FUS ΔNLS lines. Ratio C/T, ratio cytoplasmic to total FUS levels. Note absence of histones
(arrows) in the cytoplasmic fraction. Scale bars, 10 μm
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Paraspeckle assembly is directly correlated with the ex-
pression of the longer NEAT1 isoform, NEAT1_2, whereas
NEAT1_1, although recruited to paraspeckles, is not re-
quired for their integrity [35]. NEAT1_2 was recently re-
ported to be “semi-extractable” meaning that heating or
shearing steps are required to efficiently extract it by con-
ventional AGPC-based methods [11]. In order to measure
NEAT1_2 levels accurately, we included a heating step
during RNA extraction with QIAzol. NEAT1_2, quantified
by qRT-PCR, was upregulated in ΔNLS_het lines thus pro-
viding grounds for the enhanced paraspeckle assembly;
however, it was similarly upregulated in ΔNLS_ho lines
(Fig. 2d). NEAT1_1 completely overlaps with NEAT1_2 in
its 5′ end and cannot be measured separately by qRT-PCR
in total RNA samples. NEAT1_1 but not NEAT1_2 is poly-
adenylated. RNA-Seq analysis of poly(A)-captured RNA
Fig. 2 Accumulation of NEAT1 and augmented paraspeckle assembly in heterozygous FUS ΔNLS lines. a, b Cells heterozygous for the FUS NLS
deletion (ΔNLS_het) have increased number of paraspeckles, whereas homozygous (ΔNLS_ho) and FUS knockout (KO) lines are almost devoid of
paraspeckles. Arrows indicate clusters of paraspeckles in ΔNLS_het lines and arrowheads – residual paraspeckles in ΔNLS_ho lines (a). The
number of NEAT1-positive foci and their area were quantified for ΔNLS_het lines (b). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way
ANOVA with Holm-Sidak test). c Paraspeckles in ΔNLS_het cells contain both NEAT1_2 and a core paraspeckle protein NONO. d NEAT1 isoforms
are upregulated in FUS ΔNLS lines. Representative tracks for poly(A) capture RNA-Seq analysis of NEAT1 gene in a heterozygous (ΔNLS8_het) and
a homozygous (ΔNLS4_ho) lines are shown. NEAT1_1 levels were measured by RNA-Seq and NEAT1_2 levels – by qRT-PCR. N = 4 per line. *p <
0.05, ***p < 0.001, ****p < 0.0001 (one-way ANOVA). e A NEAT1-repressed transcript ADARB2 is downregulated in FUS ΔNLS lines. ADARB2 mRNA
levels were measured by RNA-Seq (left) and qRT-PCR (right). N = 3 per line. ****p < 0.0001 (one-way ANOVA with Dunnett’s test). f-h
Overexpression of FUS or its mutants restores paraspeckles in FUS KO and ΔNLS_ho cells. Arrowheads indicate mature paraspeckles or their
clusters (f, g). Inset in g shows paraspeckle primary units in a non-transfected FUS KO cell. Bar chart shows the fraction of transfected ΔNLS1_ho
and FUS KO cells with one or more paraspeckle (large NEAT1-positive dot) (h). **p < 0.01, ***p < 0.001, ****p < 0.0001 as compared to non-
transfected (NT) cells (one-way ANOVA with Holm-Sidak test). All FUS variants were expressed as N-terminal GFP-fusions. Paraspeckles were
visualised by NEAT1 RNA-FISH. Combined data for three heterozygous and three homozygous lines are referred as “het pooled” and “ho pooled”,
respectively. In b and h, numbers of cells analysed are indicated within each bar. Scale bars, 10 μm
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which only detects NEAT1_1 showed that this isoform was
also significantly elevated in FUS ΔNLS lines (Fig. 2d).
SFPQ and NONO are known to regulate NEAT1_2 levels
and hence paraspeckle formation [42]. However, mRNA
and protein levels as well as distribution of both proteins
were similar in WT and FUS ΔNLS lines (Additional file 1:
Figure S3B-D). Interestingly, FUS KO cells, which lack
paraspeckles, displayed normal NEAT1 levels (Fig. 2d),
suggesting that NEAT1 accumulation was caused by the
presence of mutant FUS and not by compensatory NEAT1
upregulation in response to paraspeckle disruption. Con-
sistent with the finding that NEAT1 is accumulated in FUS
ΔNLS lines, the NEAT1-repressed mRNA ADARB2 [24]
was found to be dramatically downregulated in these cells
(Fig. 2e), while NEAT1 knockdown was able to elevate
ADARB2 both in WT and FUS ΔNLS cells (Additional file
1: Figure S3E).
FUS itself does not stabilise NEAT1_2 and instead is
involved in paraspeckle maturation downstream of
NEAT1_2 synthesis [42, 70]. We next investigated
whether exogenously expressed mutant FUS could re-
store paraspeckle assembly in FUS KO and ΔNLS_ho
lines. Cells were transfected with plasmids to express
GFP-tagged FUS WT, FUS ΔNLS (predominantly cyto-
plasmic), and ALS-linked FUS mutants R524T and
R518K (predominantly nuclear) [54]. Overexpression of
all FUS variants led to the appearance of bright
NEAT1-positive foci in the majority of FUS KO and
ΔNLS1_ho cells (Fig. 2f-h), which coincided with the
disappearance of paraspeckle precursors (Fig. 2g).
There were no significant differences between FUS var-
iants in their ability to nucleate paraspeckles (Fig. 2h) –
despite the fact that in cells expressing GFP-tagged
FUS ΔNLS, the level of ectopic protein in the nucleus
was much lower than in cells expressing other FUS var-
iants (Fig. 2f ). This suggests that a certain threshold for
nuclear FUS level is required for paraspeckle assembly
and that FUS mutants can maintain the formation of
visible paraspeckles.
To summarise, the presence of endogenous levels of
mutant FUS is accompanied by NEAT1 upregulation.
This leads to increased paraspeckle numbers in cells
with sufficient nuclear levels of FUS. However, more
pronounced FUS mislocalisation, seen in cells expressing
two mutant copies of FUS, disrupts paraspeckles.
Mutant FUS is deficient in maintaining the integrity and
functionality of paraspeckles
Although nuclear FUS levels in ΔNLS_het lines were
sufficient to maintain (enhanced) assembly of visible
paraspeckles, it was not clear whether these structures
preserve full integrity and functionality. Core paraspeckle
proteins NONO and SFPQ interact with NEAT1_2 form-
ing a heterodimer to nucleate paraspeckle precursors,
which subsequently are bonded together by FUS. Firstly,
we used proximity ligation assay (PLA) to quantify FUS
interaction with NONO and SFPQ. This analysis re-
vealed significantly decreased interaction of FUS with
nuclear pools of both proteins in ΔNLS_het and
ΔNLS_ho lines (Fig. 3a). PLA likely detects FUS-SFPQ/
NONO interactions throughout the nucleoplasm, not
only in paraspeckles. Since FUS-SFPQ/NONO com-
plexes may have different functions in paraspeckles and
outside these structures, we sought to verify that para-
speckles formed in cells of FUS ΔNLS lines are charac-
terised by reduced interaction of FUS with the core
paraspeckle proteins. We reasoned that the signal from
the interactions between FUS and NONO/SFPQ would
be the strongest in paraspeckles because of high local
concentration of protein molecules in these compact
structures. By adjusting antibody dilutions, we eventu-
ally decreased the number of FUS-NONO PLA foci
down to ~ 5 per cell, which most likely correspond to
clusters of paraspeckles (Additional file 1: Figure S4A).
Using this protocol, we also detected significantly fewer
FUS-NONO foci in ΔNLS_het cells as compared to
WT cells (Additional file 1: Figure S4A). Thus, inter-
action of mutant FUS with core paraspeckle proteins is
decreased in the nucleoplasm and in paraspeckles.
FUS has been shown to be responsible for low
NEAT1_2 extractability (“semi-extractability”) [11].
Weakened interaction of FUS with SFPQ/NONO im-
plied its reduced binding to NEAT1_2 in FUS ΔNLS
lines. We tested whether NEAT1_2 extractability is
altered in cells expressing mutant FUS by comparing
typical RNA extraction using QIAzol with a parallel
sample subjected to an additional heating step. We first
confirmed that heating increases NEAT1_2 extractability
~ 3.5-fold in WT neuroblastoma cells, whereas extract-
ability of another lncRNA, MALAT1, is not affected
(Additional file 1: Figure S4B). In FUS KO cells that do
not form paraspeckles, NEAT1_2 was almost fully ex-
tractable (e.g. its semi-extractability was lost - heated/
non-heated ratio close to 1) (Additional file 1: Figure
S4B). We further found that NEAT1_2 extractability
was significantly increased not only in ΔNLS_ho lines al-
most lacking visible paraspeckles but also in ΔNLS_het
lines, albeit to a lesser extent (Fig. 3b).
It has been reported that FUS CLIP-Seq reads map pre-
dominantly to the 5′ region of NEAT1, with the read
density being highest in the portion of NEAT1 gene en-
coding the short NEAT1_1 isoform [32]. This raises the
possibility that FUS mediates the recruitment of NEAT1_1
into paraspeckles during higher-order assembly of para-
speckle precursors into mature paraspeckles, whereas the
deficiency of mutant FUS in paraspeckle formation would
lead to NEAT1_1 release from paraspeckles. NEAT1
gene products were shown to be enriched ~ 10-fold in
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chromatin-bound fraction [68] indicating that para-
speckles are co-pelleted with chromatin. We obtained
nuclear soluble extract (SNE) using this protocol [68]
and prepared cDNA using oligo(dT) primer in order to
amplify only polyadenylated transcripts and hence only
NEAT1_1 but not NEAT1_2. Indeed, NEAT1_1 levels
in SNE, as quantified by non-saturated PCR and
qRT-PCR, were significantly higher in FUS ΔNLS lines
as compared to WT cells (Fig. 3c), indicating abnormal
release of NEAT1_1 from paraspeckles in mutant FUS
expressing cells.
We speculated that compromised ability of mutant FUS
to maintain paraspeckle formation might become more
evident under stress conditions. To test this, we used a
viral infection mimic, synthetic dsRNA poly(I:C), a patho-
physiological stimulus reported to enhance NEAT1 syn-
thesis and paraspeckle formation [26]. In ΔNLS_het lines,
a significant proportion of poly(I:C)-treated cells had a
Fig. 3 Structural and functional deficiency of paraspeckles in FUS ΔNLS lines. a Interaction of FUS with SFPQ and NONO is reduced in FUS ΔNLS
lines as revealed by proximity ligation assay (PLA). PLA was performed in a heterozygous (ΔNLS2_het) and a homozygous (ΔNLS1_ho) lines; FUS
KO cells were used as a negative control. Representative images and quantification (number of single interactions (dots) per cell (foci per cell))
are shown. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way ANOVA with Holm-Sidak test). b Extractability of NEAT1_2 is increased in
FUS ΔNLS lines. NEAT1_2 extractability was analysed by determining its levels in QIAzol-lysed heated versus non-heated samples (“fold
extraction”) by qRT-PCR. Note near-complete NEAT1_2 extractability in FUS KO cells (fold extraction ~ 1). See also Additional file 1: Figure S4B.
N = 3 per line. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 (one-way ANOVA). c NEAT1_1 accumulates in soluble nuclear extract (SNE) in FUS
ΔNLS lines. Left, representative PCR (non-saturated conditions, 26 cycles); right, qRT-PCR analysis. A primer pair located immediately upstream
NEAT1_1 polyA-tail (NEAT1 pA) was used to quantify NEAT1_1 in cDNA of polyadenylated RNA. Note that NEAT1_2 which is not polyadenylated
is undetectable under these conditions. *p < 0.05, **p < 0.01 (one-way ANOVA with Holm-Sidak test). d NEAT1 displays diffuse distribution in
poly(I:C)-stimulated ΔNLS_het lines. Cells were analysed 8 h after poly(I:C) transfection by NEAT1 RNA-FISH. Representative images and
quantification of the fraction of cells with diffuse NEAT1 distribution are shown. e Paraspeckle-regulated miRNAs are decreased in FUS ΔNLS lines.
Levels of six mature miRNAs produced from pri-miR17~92 were measured by qRT-PCR separately for heterozygous and homozygous FUS ΔNLS
lines, and combined average values were plotted. *p < 0.05 (Mann-Whitney U-test). Combined data for three heterozygous and three
homozygous lines are referred as “het pooled” and “ho pooled”, respectively. In a and d, numbers of cells analysed are indicated within each bar.
Scale bars, 10 μm
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diffuse NEAT1 signal, as opposed to well-defined para-
speckles in all WT cells (Fig. 3d), indicating that
stress-induced paraspeckle assembly is indeed impaired in
cells expressing mutant FUS. Similar results were obtained
with another paraspeckle-inducing stressor, proteasome
inhibitor MG132 [24] (Additional file 1: Figure S4C).
Structural deficiencies in paraspeckles revealed in FUS
ΔNLS lines suggested their compromised functionality.
One established function of paraspeckles is positive regu-
lation of miRNA biogenesis; in particular, paraspeckles
regulate processing of pri-miR-17~92 transcript by enhan-
cing the Microprocessor activity [27]. We found a signifi-
cant decrease in the levels of six miRNAs produced from
this miRNA precursor not only in homozygous but also in
heterozygous FUS ΔNLS lines (Fig. 3e).
We next sought to corroborate these findings in another
cellular system, human fibroblasts expressing mutant
FUS. Fibroblasts are well suited for paraspeckle analysis as
these cells have a large nucleus with numerous para-
speckles. In fibroblasts bearing P525L mutation FUS dis-
played only mild cytoplasmic mislocalisation (Fig. 4a).
Consistent with data from neuroblastoma cells, para-
speckle numbers and NEAT1 positive area were increased
~ 2-fold in mutant FUS fibroblasts (Fig. 4b). Although we
did not observe abnormalities in paraspeckle appearance
in FUS P525L cells using NEAT1_2 probe (Fig. 4b), strik-
ing non-paraspeckle NEAT1 distribution was observed in
these cells using a probe which detects both NEAT1 iso-
forms (total NEAT1, 5′ segment probe) (Fig. 4c). Since
NEAT1_2 FISH did not produce a diffuse signal, we
Fig. 4 Localisation of NEAT1_1 outside paraspeckles in patient fibroblasts bearing FUS mutation. a FUS is predominantly nuclear in human
patient fibroblasts bearing FUS P525L mutation. b Paraspeckle assembly is augmented in FUS P525L human fibroblasts. Paraspeckles were
visualised by NEAT1_2 (3′ segment probe) RNA-FISH. *p < 0.05 (Mann-Whitney U-test). c Diffuse, non-paraspeckle distribution of NEAT1 in FUS
P525L fibroblasts revealed using RNA-FISH with 5′ segment NEAT1 probe (total NEAT1). d NEAT1_1 is abnormally localised to nuclear speckles
in FUS P525L fibroblasts. Representative images and quantification of the fraction of cells with speckle-localised NEAT1 are shown. Total NEAT1
(5′ segment probe) was used, and speckles were visualised by polyA+ RNA FISH. In b and d, numbers of cells analysed are indicated within bars.
Scale bars, 10 μm
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concluded that this abnormally localised NEAT1 corre-
sponds to NEAT1_1. Co-localisation analysis with a polyA+
RNA, a speckle marker, showed that NEAT1_1 was mainly
present on the border and/or inside speckles (Fig. 4d). This
pattern is similar to NEAT1_1 ‘microspeckle’ distribution
in cells lacking NEAT1_2/paraspeckles [35]. In an inde-
pendent P525L fibroblast line, obtained from the same pa-
tient, but at the presymptomatic disease stage, RNA-FISH
with total NEAT1 probe also detected paraspeckle disrup-
tion (Additional file 1: Figure S5). These data are in line
with NEAT1_1 accumulation in nuclear soluble fraction
(SNE) in FUS ΔNLS lines (Fig. 3c) and further confirm that
ALS-linked mutations likely compromise the ability of FUS
protein to sequester NEAT1_1 into paraspeckles.
Overall, the above results indicate that the capability
of mutant FUS to maintain structural integrity and func-
tionality of paraspeckles is impaired even in cells with
minor cytoplasmic redistribution of the protein.
Paraspeckles are formed in spinal neurons and glia of
ALS-FUS patients
Spinal motor neurons and glial cells in sALS and fALS
with TDP-43 pathology are characterised by de novo
paraspeckle assembly [53]. We examined paraspeckle
formation in human spinal cord sections of ALS-FUS
patients by NEAT1 RNA-FISH. Three ALS-FUS cases
characterised by early disease onset and, similar to the
majority of ALS-FUS cases, predominantly spinal motor
neuron degeneration [29], were included in the analysis
(Additional file 1: Table S2); sALS cases served as a posi-
tive control. Paraspeckles were detected in all three
ALS-FUS cases examined, on average being present in
27% spinal neurons (Fig. 5a, Additional file 1: Table S2),
similar to what is observed in sALS and other fALS cases
[53]. We also confirmed this result using RNAscope® ISH
with NEAT1_2 probe (Fig. 5b). Paraspeckles were also
often detected in glial cells (Fig. 5a, b). Thus, paraspeckle
hyper-assembly in the spinal cord cells is a phenomenon
shared by the majority of ALS cases including ALS-FUS.
In our previous study, we found that NONO is mislo-
calised and aggregated in ALS-FUS [55]. We examined
SFPQ distribution in the same ALS-FUS cases. Although
SFPQ was accumulated in the nucleus of neurons and
glial cells in ALS-FUS cases, its mislocalisation or aggrega-
tion was not observed (Additional file 1: Figure S6). We
also studied the behaviour of overexpressed GFP-tagged
Fig. 5 Accumulation of paraspeckles in spinal neurons and glial cells in ALS-FUS. a Examples of paraspeckles in spinal neurons and glial cells of
ALS-FUS and sALS patients visualised using RNA-FISH with fluorescently-labelled (Quasar 570) 5′ segment NEAT1 probe. Images were taken both
in the orange and green channels to distinguish between specific NEAT1 signal and autofluorescence from lipofuscin. See also Additional file 1:
Table S2. Arrowheads point to paraspeckles in a glial cell. Scale bars, 10 μm. b Examples of paraspeckles in spinal neurons (left panels) and glial
cells (right panels) in an ALS-FUS patient visualised with RNAscope® ISH using NEAT1_2 probe. Neuronal nuclei are circled. Scale bars, 10 μm (left
panels) and 50 μm (right panels)
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SFPQ and NONO in primary mouse neurons. In agree-
ment with the post-mortem data, overexpressed SFPQ
was confined to the nucleus, whereas NONO often mis-
localised and aggregated in the cytoplasm of neurons
(Additional file 1: Figure S7). Therefore nuclear SFPQ dis-
tribution is preserved in ALS-FUS allowing enhanced
NEAT1 accumulation and paraspeckle assembly.
Discussion
In the current study we provide evidence that accumula-
tion of structurally and functionally compromised para-
speckles may serve as a novel pathomechanism in
ALS-FUS. Our study reinforces the notion of enhanced
paraspeckle assembly in spinal neurons and glia as a
hallmark of ALS. Indeed, we show that paraspeckle for-
mation is typical even for ALS cases with the pathology
of a structural paraspeckle protein.
Paraspeckles exert anti-apoptotic activity and increase
viability of cells under stressful conditions [24, 53, 67],
therefore their formation in motor neurons at the early
stages of pathological process in ALS may serve as a
mechanism to prolong neuronal survival. However, al-
though cells expressing mutant FUS, similar to TDP-43
depleted cells [53], are characterised by paraspeckle
hyper-assembly, FUS mutations would impact on para-
speckle functionality. Disruption of paraspeckle-dependent
neuroprotection may thus contribute to the particularly
aggressive disease phenotype (early onset and fast progres-
sion) typical for ALS-FUS [2].
Comparison of our homozygous and heterozygous FUS
ΔNLS cell lines revealed that the presence of WT FUS
ameliorates mislocalisation of mutant FUS, possibly by
retaining the mutant protein in the nucleus via interac-
tions between normal and mutant FUS. It remains to be
established whether nuclear retention of mutant FUS is
protective or rather detrimental – e.g. by exacerbating
toxic gain of function in the nucleus, including via para-
speckles. Results of previous studies of nuclear RNA gran-
ules also support gain of nuclear toxicity by mutant FUS
as a disease mechanism. For example, a negative effect of
mutant FUS on nuclear bodies Gems independent of its
cytoplasmic mislocalisation has been demonstrated [57,
71]. In addition, FUS mutations may impact on its nuclear
functions by affecting target gene expression directly [60]
or via altered chromatin structure [63]. Of note, compo-
nents of the chromatin remodelling complex can be re-
cruited to paraspeckles [28]. Our results suggest that
nuclear gain of function by mutant FUS may play a more
important role in ALS-FUS pathogenesis than previously
believed.
We found that in contrast to NONO, SFPQ does not
mislocalise or aggregate in ALS-FUS, moreover, its nu-
clear levels are increased compared to control cases.
This accumulation might play a compensatory role and
serve to ameliorate the effects of NONO and FUS loss of
function. Elevated SFPQ levels would also promote NEAT1
accumulation, however, since SFPQ is not significantly
upregulated in FUS ΔNLS lines which nevertheless accu-
mulate NEAT1, additional mechanisms are likely to be in-
volved. Our transcriptomic analysis of FUS ΔNLS did not
highlight any significantly dysregulated cellular pathways
which could explain for NEAT1 upregulation (data not
shown). It is plausible that small changes in the function of
multiple pathways in mutant FUS expressing cells synergise
to affect NEAT1 expression. In addition, our RNA-Seq ana-
lysis provided relatively low read coverage (~ 20M reads/
sample) and thus did not capture possible changes in the
levels of low-abundance transcripts which may have im-
pacted on NEAT1 levels. Alternatively, abnormal NEAT1
regulation can be realised at the level of posttranslational
protein modifications [25].
An immediate consequence of altered structural in-
tegrity of paraspeckles in cells expressing mutant FUS
is the release of NEAT1_1. NEAT1_1 is among the
most abundant lncRNAs in human cells [22, 35] includ-
ing those lacking paraspeckles, such as neurons. It
functions to modulate transcription, including via regu-
lation of chromatin active state [7, 35, 69]. It is highly
likely that elevated levels of NEAT1_1 in neurons will
cause wide-spread changes in gene expression. Re-
cently, NEAT1_1 has been shown to interact with the
p53 pathway [1, 40] and modulate neuronal excitability
[5]. The latter study is especially intriguing because it
suggests that elevated neuronal NEAT1_1 levels in ALS
may directly contribute to their abnormal excitability
[4]. Further studies are required to decipher molecular
mechanisms responsible for NEAT1 upregulation and
to establish whether accumulated NEAT1_1 is a signifi-
cant driver of global gene expression changes in mutant
FUS expressing cells.
Another important finding of our current study rele-
vant to ALS pathogenesis is the severe repression of
ADARB2 expression in mutant FUS expressing cells.
ADARB2 is mainly expressed in the nervous system and
was shown to be sequestered into C9ORF72 foci sug-
gesting loss of its function in ALS-C9 [17], although
possible functional consequences of this effect are yet to
be addressed. ADARB2 depletion, despite mediated by a
different upstream mechanism, might be a converging
phenotype in ALS-FUS and ALS-C9.
Finally, our results suggest that the role of FUS in
miRNA biogenesis [41] can be at least in part mediated
by paraspeckles, and now it needs to be addressed to
what extent pri-miRNA processing relies on the assem-
bly of mature paraspeckles by FUS.
In conclusion, our study identifies a novel molecular
phenotype driven by loss and gain of nuclear function of
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mutant FUS which may contribute to the disease sever-
ity in ALS-FUS.
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